Reuters - Video

Edition: US | UK | IN | CN | JP

video Business

Nissan in talks to buy France's Renault stake
Nissan in talks to buy France's Renault stake - 01:03
ECB drops easing bias, in baby step towards QE exit
ECB drops easing bias, in baby step towards QE exit - 01:54
Electric sports cars blur need for speed
Electric sports cars blur need for speed - 01:40
Kroger's forecast disappoints Wall Street
Kroger's forecast disappoints Wall Street - 01:01
ECB drops easing bias en route to stimulus exit
ECB drops easing bias en route to stimulus exit - 02:57
China's aluminium exports rise as U.S. tariffs loom
China's aluminium exports rise as U.S. tariffs loom - 01:44
Britain eyes £65 bln trade ties with Saudi Arabia
Britain eyes £65 bln trade ties with Saudi Arabia - 01:41
Tariffs won't hurt Boeing, but retaliation will
Tariffs won't hurt Boeing, but retaliation will - 01:13
Cohn's exit rattles markets
Cohn's exit rattles markets - 02:18
Buy Boeing shares despite fears of tariffs, says Sylvia Jablonski
Buy Boeing shares despite fears of tariffs, says Sylvia Jablonski - 06:39
Cohn's departure deepens uncertainty on Wall Street
Cohn's departure deepens uncertainty on Wall Street - 02:04

Breakingviews TV: Unhealthy M&A

12:42pm EST - 03:34

Antony Currie and Robert Cyran explain why insurer Cigna is spending $54 bln for drugs middleman Express Scripts – and how it’s undermining the rationale behind the deal by paying a 31 pct premium that cost cuts can’t cover.

▲ Hide Transcript

▶ View Transcript

Antony Currie and Robert Cyran explain why insurer Cigna is spending $54 bln for drugs middleman Express Scripts – and how it’s undermining the rationale behind the deal by paying a 31 pct premium that cost cuts can’t cover.

Press CTRL+C (Windows), CMD+C (Mac), or long-press the URL below on your mobile device to copy the code

Close

Breakingviews TV: Unhealthy M&A

12:42pm EST - 03:34